ebook Munafa Stock Market Course + Intraday & FNO calls  

       

MAHE announcements 12-month Highs Etfs announcements and dividends declared INDICES

12-month Highs Etfs Complete list of announcements declared & dividend announcements by 12-month Highs Etfs MAHE

12-month Highs Etfs MAHE listed on INDICES and deals in

Announcements and dividends declared by 12-month Highs Etfs MAHE

Adani Portfolio maintains double-digit growth, achieves record EBITDA for 12 months ending Dec'24
India's largest infrastructure group with businesses in cement and mining, has continued its strong double-digit growth despite external challenges.
Announcement as on 20 February 2025

Stocks to buy in 2025: ICICI Bank, IGL among top 5 trading ideas that could give 27-50% return in 12 months
Brokerage firms recommend buying PI Industries, ICICI Bank, Amber Enterprises, Indus Towers, and IGL. PI Industries is targeted at Rs 4,400. ICICI Bank is expected to reach Rs 1,600. Amber Enterprises has a target of Rs 8,845. Indus Towers is aimed at Rs 4
Announcement as on 18 February 2025

Dip in M&M shares 1-2-day affair; consumer discretionary stocks to pip staples over 6-12 months: Amnish Aggarwal
M&M shares might dip momentarily, but their medium-term outlook remains positive with robust performance in the auto sector. Pharma, particularly generics, biosimilars, and CDMO, is expected to do well. Consumer stocks poised for growth, especially dis
Announcement as on 18 February 2025

Stocks to buy in 2025: Lupin, Ashok Leyland among top 5 stocks that could give up to 10-60% return in 12 months
Top brokerage firms have identified key stocks for potential investment over the next year, highlighting Lupin, Ashok Leyland, Power Finance Corporation, Jubilant FoodWorks, and Siemens for substantial returns. Recommendations suggest substantial upsides r
Announcement as on 14 February 2025

Stocks to buy in 2025: L&T, Tata Motors among 5 stocks that could see 15-30% upside in 12 months
Nomura has reaffirmed its "Buy" rating on Larsen & Toubro (L&T), citing its robust order book and execution strength. Meanwhile, Choice Broking remains positive on Ajanta Pharma, driven by its specialty therapies and margin expansion.
Announcement as on 03 February 2025

Announcements by 12-month Highs Etfs first page | Next page | Prev page |

MAHE 12-month Highs Etfs current price & indicator signals

Moving Averages for 12-month Highs Etfs

  • 5Day Average: 356.4
  • 12Day Average: 308
  • 20Day Average: 312.65
  • 50Day Average: 235.48
  • 100Day Average: 316.25
  • 150Day Average: 312.95
  • 200Day Average: 262.12

MAHE Indicators & signals

Indicator MACD (12,26,9)

295.11, 275.09, 25.9
Indicator MACD is in positive zone

Indicator ADX (14)

8.49, 45.76, 54.24
Indicator ADX is indicating that momentum is weak.
Momentum is towards selling.

Indicator RSI (14)

Current RSI is: 44
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of MAHE 12-month Highs Etfs are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
29 Mon Dec 2025 124.00 124.00 to 124.00 -71.88% 1.02 times
26 Fri Dec 2025 441.00 441.00 to 441.00 3.28% 0.97 times
24 Wed Dec 2025 427.00 427.00 to 427.00 2.15% 0.94 times
23 Tue Dec 2025 418.00 418.00 to 418.00 12.37% 1.02 times
22 Mon Dec 2025 372.00 372.00 to 372.00 95.79% 1.03 times
19 Fri Dec 2025 190.00 190.00 to 190.00 131.71% 1 times
18 Thu Dec 2025 82.00 82.00 to 82.00 78.26% 1.01 times
17 Wed Dec 2025 46.00 46.00 to 46.00 -4.17% 1.01 times
16 Tue Dec 2025 48.00 48.00 to 48.00 -80.33% 1.01 times
15 Mon Dec 2025 244.00 244.00 to 244.00 -49.9% 1 times
12 Fri Dec 2025 487.00 487.00 to 487.00 -40.39% 1.01 times
11 Thu Dec 2025 817.00 817.00 to 817.00 20.86% 1 times

Videos related to: MAHE announcements 12-month Highs Etfs announcements and dividends declared INDICES

Hindi Video Correct Way Of Fundamental Analysis Using EPS And PE - MunafaSutra

Hindi Video What Is Needed To Succeed In Stock Markets

MAHE announcements 12-month Highs Etfs announcements and dividends declared INDICES

 

Back to top